Uri Aharon - RedHill Biopharma Insider

REDIF -- USA Stock  

USD 0.75  0.00  0.00%

  Executive
Mr. Uri Hananel Aharon serves as Chief Accounting Officer at Redhill Biopharma Ltd, effective since 2012. His work experience includes the following roles Team Manager at Ernst Young Israel and Accounting Intern at Ziv Haft, BDO . He holds a Bachelors degree in Accounting and Economics from The Hebrew University of Jerusalem and a MBA degree, majoring in Business Taxation, from the College of Management Academic Studies, Rishon LeZion.
Age: 35  Executive Since 2011  MBA    
972 3 541 3131  http://www.redhillbio.com
Aharon is a graduate of the Hebrew University and the Academic College for Management, Rishon Lezion .

Management Efficiency

The company has return on total asset (ROA) of (29.24) % which means that it has lost $29.24 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (21.0) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 969.85 K in total debt with debt to equity ratio (D/E) of 0.06 which may suggest the company is not taking enough advantage from borrowing. RedHill Biopharma Ltd has Current Ratio of 5.72 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Found 11 records

EXECUTIVE Since

Mingguang LiCHINA LIFE INSURANCE LTD
2017
Qi RuanCHINA LIFE INSURANCE LTD
2016
Cheryll SerenoMegaworld Corporation
2018
Yong ZhengCHINA LIFE INSURANCE LTD
2013
Anna LlovidoMegaworld Corporation
2014
Rolando SiatelaMegaworld Corporation
N/A
Joseph LacsonMetro Pacific Investments Corpo
2016
Johann QuiazonMegaworld Corporation
2017
Zhong ZhanCHINA LIFE INSURANCE LTD
1968
Jiade LiuCHINA LIFE INSURANCE LTD
2015
Cristina GilFernandezMetro Pacific Investments Corpo
2013

Entity Summary

RedHill Biopharma Ltd., a biopharmaceutical company, primarily focuses on the development and commercialization of late clinicalstage, proprietary, orallyadministered, small molecule drugs for the treatment of inflammatory and gastrointestinal diseases, and cancer. RedHill Biopharma Ltd (REDIF) is traded on OTC Market in USA. It is located in Tel Aviv, and employs 12 people.

RedHill Biopharma Leadership Team

Patricia Anderson, Vice President - Regulatory Affairs
Micha Chorin, CFO
Ofer Tsimchi, Director
Patrick Mclean, Product Manager
Aida Bibliowicz, Vice President - Clinical Affairs Europe
Ori Shilo, Co-Founder and Deputy CEO of Fin. and Operations
Shmuel Cabilly, Director
Dror BenAsher, Chairman of the Board, CEO
Kenneth Reed, Director
Elkan Gamzu, Product Manager
Adi Frish, Sr. VP of Bus. Devel. and Licensing
Guy Goldberg, Chief Business Officer
Reza Fathi, Sr. VP of RandD
Tom Lang, Vice President - Regulatory & Clinical Affairs
Clara Fehrmann, Product Manager
Pascal Weerts, Director - Corporate and Legal Affairs
Eric Swenden, Director
Dan Suesskind, Director
Gilead Raday, Senior Vice President - Product and Corporate Development
Rick Scruggs, Director
Terry Plasse, Medical Director
Danielle Abramson, Director - Intellectual Property & Research
Uri Aharon, Chief Accounting Officer
Shani Maurice, Vice President - Business Development & Communications
Patricia Bandeira, Product Manager - Oncology
Ira Kalfus, Medical Director
Nurit Benjamini, External Director

Stock Performance Indicators

Current Sentiment - REDIF

RedHill Biopharma Investor Sentiment

Macroaxis portfolio users are evenly split in their perspective on investing in RedHill Biopharma Ltd. What is your perspective on investing in RedHill Biopharma Ltd? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip
Currently Active Assets on Macroaxis
CRM   
Purchased a lot of shares of
a day ago
Traded for 156.0
CRM   
Purchased a lot of shares of
a day ago
Traded for 156.0
F   
Purchased over 300 shares of
a day ago
Traded for 9.81
C   
Purchased over 40 shares of
a day ago
Traded for 74.735
GM   
Purchased over 70 shares of
a day ago
Traded for 36.08
Additionally take a look at Your Equity Center. Please also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Search macroaxis.com